Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population‐based analysis

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|119|19|3489-3495

ISSN: 0008-543x

Source: CANCER, Vol.119, Iss.19, 2013-10, pp. : 3489-3495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract